GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a major focus in medical investigation, largely due to its notable impact on controlling conditions such as second type diabetes and weight gain. New studies have revealed that beyond glucose management, GLP-1 agonists